CATALYST PHARMACEUTICALS, INC. (CPRX)

Latest Insider Confidence Score

2026Q1

48.8
Bearish

Company insider confidence (by quarter)

2012Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Biomarin Pharmaceutical Inc 10% Owner 6,666,667 Dec 12, 2012
McEnany Patrick J Director 4,373,477 Dec 3, 2025
Huckel Hubert E Md Director 1,354,170 Oct 6, 2014
Miller Steve Chief Op. & Scientific Officer 1,076,197 Nov 24, 2025
O'Keeffe Charles B Director 736,470 Feb 19, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 17, 2026 Feb 19, 2026 Russo Gregg Chief HR Officer Neutral 47.5 -211 -30.71% ✗ -
Jan 5, 2026 Jan 6, 2026 Kalb Michael Wayne CFO Neutral 47.5 -2,080 -13.21% ✗ -
Jan 5, 2026 Jan 6, 2026 Daly Richard J CEO Neutral 47.5 -10,577 -3.75% ✗ -
Dec 29, 2025 Dec 30, 2025 DENKHAUS DONALD A Director Neutral 52.5 - 0.00% ✗ -
Dec 29, 2025 Dec 30, 2025 Elsbernd Brian Chief Compliance/Legal Officer Neutral 47.5 -2,623 -1.07% ✗ -
Dec 29, 2025 Dec 30, 2025 Tierney David S Director Neutral 52.5 - 0.00% ✗ -
Dec 29, 2025 Dec 30, 2025 Sundaram Preethi Chief Strategy Officer Neutral 47.5 -2,369 -4.14% ✗ -
Dec 29, 2025 Dec 30, 2025 Miller Steve Chief Op. & Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 29, 2025 Dec 30, 2025 Harper Molly Director Neutral 52.5 - 0.00% ✗ -
Dec 29, 2025 Dec 30, 2025 MCENANY PATRICK J Director Neutral 52.5 -6,786 -0.16% ✗ -
Dec 29, 2025 Dec 30, 2025 Daly Richard J CEO Neutral 52.5 -524 -0.22% ✗ -
Dec 29, 2025 Dec 30, 2025 Del Carmen Jeffrey Chief Commercial Officer Neutral 47.5 -3,839 -21.12% ✗ -
Dec 12, 2025 Dec 16, 2025 Harper Molly Director Sell 20.0 -26,746 -91.89% ✗ $621.9K
Dec 8, 2025 Dec 10, 2025 Elsbernd Brian Chief Compliance/Legal Officer Neutral 47.5 -2,780 -1.15% ✗ -
Dec 8, 2025 Dec 10, 2025 Miller Steve Chief Op. & Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 8, 2025 Dec 10, 2025 Tierney David S Director Neutral 52.5 - 0.00% ✗ -
Dec 8, 2025 Dec 10, 2025 Thompson Tamar Director Neutral 52.5 - 0.00% ✗ -
Dec 8, 2025 Dec 10, 2025 Del Carmen Jeffrey Chief Commercial Officer Neutral 47.5 -2,492 -20.76% ✗ -
Dec 8, 2025 Dec 10, 2025 Harper Molly Director Neutral 52.5 - 0.00% ✗ -
Dec 8, 2025 Dec 10, 2025 MCENANY PATRICK J Director Neutral 52.5 - 0.00% ✗ -
Dec 8, 2025 Dec 10, 2025 DENKHAUS DONALD A Director Neutral 52.5 - 0.00% ✗ -
Dec 8, 2025 Dec 10, 2025 Sundaram Preethi Chief Strategy Officer Neutral 47.5 -1,669 -3.20% ✗ -
Dec 1, 2025 Dec 3, 2025 MCENANY PATRICK J Director Neutral 27.5 -135,000 -1.05% ✗ -
Nov 26, 2025 Nov 28, 2025 Del Carmen Jeffrey Chief Commercial Officer Sell 20.0 -10,983 -73.49% ✗ $256.2K
Nov 21, 2025 Nov 24, 2025 Sundaram Preethi Chief Strategy Officer Neutral 47.5 -1,364 -2.92% ✗ -
Nov 21, 2025 Nov 24, 2025 Miller Steve Chief Op. & Scientific Officer Neutral 52.5 - 0.00% ✗ -
Nov 20, 2025 Nov 24, 2025 Russo Gregg Chief HR Officer Neutral 52.5 - 0.00% ✗ -
Nov 21, 2025 Nov 24, 2025 Thompson Tamar Director Neutral 52.5 - 0.00% ✗ -
Nov 21, 2025 Nov 24, 2025 Kalb Michael Wayne CFO Neutral 47.5 -2,485 -22.41% ✗ -
Nov 21, 2025 Nov 24, 2025 Tierney David S Director Neutral 52.5 - 0.00% ✗ -
Nov 21, 2025 Nov 24, 2025 MCENANY PATRICK J Director Neutral 52.5 - 0.00% ✗ -
Nov 21, 2025 Nov 24, 2025 Harper Molly Director Neutral 52.5 - 0.00% ✗ -
Nov 21, 2025 Nov 24, 2025 Daly Richard J CEO Neutral 47.5 -7,872 -3.19% ✗ -
Nov 21, 2025 Nov 24, 2025 DENKHAUS DONALD A Director Neutral 52.5 - 0.00% ✗ -
Nov 21, 2025 Nov 24, 2025 Elsbernd Brian Chief Compliance/Legal Officer Neutral 50.0 -2,030 -0.86% ✗ -
Nov 21, 2025 Nov 24, 2025 Del Carmen Jeffrey Chief Commercial Officer Neutral 47.5 -1,641 -29.29% ✗ -
Nov 20, 2025 Nov 24, 2025 Curran Daniel J. Director Neutral 52.5 - 0.00% ✗ -
Nov 20, 2025 Nov 24, 2025 Andrews William T. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 12, 2025 Nov 14, 2025 Elsbernd Brian Chief Compliance/Legal Officer Buy 97.5 +40,000 20.94% ✗ $908K
Sep 8, 2025 Sep 10, 2025 Elsbernd Brian Chief Compliance/Legal Officer Sell 40.0 -30,000 -9.97% ✗ $609K
Sep 3, 2025 Sep 5, 2025 Elsbernd Brian Chief Compliance/Legal Officer Sell 20.0 -50,000 -11.71% ✗ $987.2K
Aug 27, 2025 Aug 28, 2025 Tierney David S Director Sell 20.0 -26,000 -6.41% ✗ $525.2K
Aug 26, 2025 Aug 28, 2025 Miller Steve Chief Op. & Scientific Officer Sell 17.5 -115,000 -10.80% ✗ $2.3M
Aug 26, 2025 Aug 28, 2025 Daly Richard J CEO Sell 40.0 -22,970 -9.20% ✗ $473.6K
Aug 8, 2025 Curran Daniel J. Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2025 Jun 12, 2025 Sundaram Preethi Chief Strategy Officer Sell 22.5 -3,924 -8.72% ✗ $103.6K
Jun 6, 2025 Jun 10, 2025 MCENANY PATRICK J Director Sell 16.3 -200,000 -4.46% ✗ $5.2M
Jun 6, 2025 Andrews William T. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 3, 2025 Daly Richard J CEO Buy 100.0 +70,000 53.94% ✗ $1.7M
May 13, 2025 May 15, 2025 INGENITO GARY Chief Med. & Reg. Officer Sell 16.3 -244,000 -63.92% ✗ $5.8M
Mar 5, 2025 Mar 7, 2025 INGENITO GARY Chief Med. & Reg. Officer Sell 17.5 -225,000 -62.03% ✗ $4.9M
Mar 3, 2025 Mar 5, 2025 Elsbernd Brian Chief Compliance/Legal Officer Sell 17.5 -62,975 -14.31% ✗ $1.4M
Mar 3, 2025 Mar 5, 2025 Del Carmen Jeffrey Chief Commercial Officer Sell 20.0 -30,423 -100.00% ✗ $696.4K
Feb 28, 2025 Russo Gregg Chief HR Officer Neutral 52.5 - 0.00% ✗ -
Feb 26, 2025 Russo Gregg Chief HR Officer Neutral 52.5 - 0.00% ✗ -
Feb 14, 2025 Feb 19, 2025 Daly Richard J CEO Neutral 50.0 -1,574 -0.58% ✗ -
Feb 14, 2025 Feb 19, 2025 Tierney David S Director Neutral 52.5 - 0.00% ✗ -
Feb 14, 2025 Feb 19, 2025 DENKHAUS DONALD A Director Neutral 52.5 - 0.00% ✗ -
Feb 14, 2025 Feb 19, 2025 Miller Steve Chief Op. & Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 14, 2025 Feb 19, 2025 Harper Molly Director Neutral 52.5 - 0.00% ✗ -
Feb 14, 2025 Feb 19, 2025 INGENITO GARY Chief Med. & Reg. Officer Neutral 47.5 -2,435 -3.41% ✗ -
Feb 14, 2025 Feb 19, 2025 Del Carmen Jeffrey Chief Commercial Officer Neutral 47.5 -3,125 -9.32% ✗ -
Feb 14, 2025 Feb 19, 2025 Sundaram Preethi Chief Strategy Officer Neutral 47.5 -5,965 -11.70% ✗ -
Feb 14, 2025 Feb 19, 2025 O'Keeffe Charles B Director Neutral 52.5 - 0.00% ✗ -
Feb 14, 2025 Feb 19, 2025 Elsbernd Brian Chief Compliance/Legal Officer Neutral 47.5 -2,353 -1.23% ✗ -
Jan 8, 2025 Jan 10, 2025 DENKHAUS DONALD A Director Neutral 52.5 - 0.00% ✗ -
Jan 2, 2025 Jan 3, 2025 Kalb Michael Wayne CFO Neutral 47.5 -2,941 -41.20% ✗ -
Jan 2, 2025 Jan 3, 2025 Daly Richard J CEO Neutral 47.5 -10,600 -3.81% ✗ -
Dec 27, 2024 Dec 31, 2024 Miller Steve Chief Op. & Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 27, 2024 Dec 31, 2024 O'Keeffe Charles B Director Neutral 52.5 - 0.00% ✗ -
Dec 27, 2024 Dec 31, 2024 Tierney David S Director Neutral 52.5 - 0.00% ✗ -
Dec 27, 2024 Dec 31, 2024 INGENITO GARY Chief Med. & Reg. Officer Neutral 47.5 -3,541 -5.46% ✗ -
Dec 27, 2024 Dec 31, 2024 Daly Richard J CEO Neutral 52.5 -324 -0.14% ✗ -
Dec 27, 2024 Dec 31, 2024 Elsbernd Brian Chief Compliance/Legal Officer Neutral 47.5 -1,941 -1.06% ✗ -
Dec 27, 2024 Dec 31, 2024 DENKHAUS DONALD A Director Neutral 52.5 - 0.00% ✗ -
Dec 27, 2024 Dec 31, 2024 Del Carmen Jeffrey Chief Commercial Officer Neutral 47.5 -3,839 -14.37% ✗ -
Dec 27, 2024 Dec 31, 2024 Harper Molly Director Neutral 52.5 - 0.00% ✗ -
Dec 27, 2024 Dec 31, 2024 Sundaram Preethi Chief Strategy Officer Neutral 47.5 -2,345 -6.40% ✗ -
Dec 13, 2024 Dec 17, 2024 Miller Steve Chief Op. & Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 9, 2024 Dec 11, 2024 Miller Steve Chief Op. & Scientific Officer Sell 17.5 -50,000 -6.78% ✗ $1.1M
Dec 9, 2024 Dec 11, 2024 Thompson Tamar Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2024 Dec 11, 2024 INGENITO GARY Chief Med. & Reg. Officer Neutral 47.5 -2,891 -4.92% ✗ -
Dec 9, 2024 Dec 11, 2024 Tierney David S Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2024 Dec 11, 2024 Elsbernd Brian Chief Compliance/Legal Officer Neutral 50.0 -1,720 -0.96% ✗ -
Dec 9, 2024 Dec 11, 2024 Harper Molly Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2024 Dec 11, 2024 MCENANY PATRICK J Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2024 Dec 11, 2024 DENKHAUS DONALD A Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2024 Dec 11, 2024 O'Keeffe Charles B Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2024 Dec 11, 2024 Del Carmen Jeffrey Chief Commercial Officer Neutral 47.5 -2,355 -11.54% ✗ -
Dec 9, 2024 Dec 11, 2024 Sundaram Preethi Chief Strategy Officer Neutral 47.5 -2,415 -7.45% ✗ -
Nov 27, 2024 Nov 29, 2024 INGENITO GARY Chief Med. & Reg. Officer Sell 20.0 -12,000 -18.93% ✗ $272.7K
Nov 27, 2024 Nov 29, 2024 Harper Molly Director Sell 20.0 -17,500 -100.00% ✗ $385K
Nov 26, 2024 Nov 29, 2024 Elsbernd Brian Chief Compliance/Legal Officer Sell 20.0 -13,256 -3.79% ✗ $286.7K
Nov 21, 2024 Nov 25, 2024 Del Carmen Jeffrey Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Nov 21, 2024 Nov 25, 2024 Sundaram Preethi Chief Strategy Officer Neutral 52.5 - 0.00% ✗ -
Nov 21, 2024 Nov 25, 2024 MCENANY PATRICK J Director Neutral 52.5 - 0.00% ✗ -
Nov 21, 2024 Nov 25, 2024 Miller Steve Chief Op. & Scientific Officer Neutral 52.5 - 0.00% ✗ -
Nov 21, 2024 Nov 25, 2024 DENKHAUS DONALD A Director Neutral 52.5 - 0.00% ✗ -
Nov 21, 2024 Nov 25, 2024 INGENITO GARY Chief Med. & Reg. Officer Neutral 52.5 - 0.00% ✗ -
Nov 21, 2024 Nov 25, 2024 Tierney David S Director Neutral 52.5 - 0.00% ✗ -